187 related articles for article (PubMed ID: 19915849)
1. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium.
Choi JS; Kim MJ; Choi JY; Park MS; Lim JS; Kim KW
Eur Radiol; 2010 May; 20(5):1052-60. PubMed ID: 19915849
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH
Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.
Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS
J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533
[TBL] [Abstract][Full Text] [Related]
4. Diffusion- and T₂-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium.
Muhi A; Ichikawa T; Motosugi U; Sou H; Sano K; Araki T
Magn Reson Med Sci; 2012; 11(3):185-91. PubMed ID: 23037563
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
6. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
8. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
9. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
[TBL] [Abstract][Full Text] [Related]
10. Quantitative diffusion weighted imaging in patients with hepatocellular carcinoma: effects of simultaneous multi-slice acceleration and gadoxetic acid administration.
Yang T; Ye Z; Yao S; Wu Y; Yin T; Song B
Abdom Radiol (NY); 2024 Mar; 49(3):683-693. PubMed ID: 37930449
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
12. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging.
Firat AK; Sanli B; Karakaş HM; Erdem G
Neuroradiology; 2006 Jul; 48(7):465-70. PubMed ID: 16673073
[TBL] [Abstract][Full Text] [Related]
15. The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI.
Yang DM; Jahng GH; Kim HC; Jin W; Ryu CW; Nam DH; Lee YK; Park SY
Br J Radiol; 2011 Apr; 84(1000):319-26. PubMed ID: 20959371
[TBL] [Abstract][Full Text] [Related]
16. Conspicuity of Malignant Liver Tumors on Diffusion-Weighted Imaging With Short tau Inversion Recovery After Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid Administration.
Iwanaga T; Fukukura Y; Saito T; Sasaki M; Kumagae Y; Takumi K; Hakamada H; Fujisaki T; Saigo Y; Yoshiura T
J Magn Reson Imaging; 2019 Feb; 49(2):565-573. PubMed ID: 30102432
[TBL] [Abstract][Full Text] [Related]
17. Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC).
Cieszanowski A; Podgórska J; Rosiak G; Maj E; Grudziński IP; Kaczyński B; Szeszkowski W; Milczarek K; Rowiński O
Pol J Radiol; 2016; 81():103-9. PubMed ID: 27026795
[TBL] [Abstract][Full Text] [Related]
18. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.
Choi SA; Lee SS; Jung IH; Kim HA; Byun JH; Lee MG
Br J Radiol; 2012 Jan; 85(1009):29-36. PubMed ID: 21123305
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
20. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
